Top Abstract Purchase Related
Home
>
Node
>
Subnode

Idiopathic inflammatory myopathies

Gendek-Kubiak, H.

Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 18(107): 590-594

2005

ISSN/ISBN: 1426-9686
PMID: 16161963
Document Number: 591792
The following disease entities are being included into the idiopathic inflammatory myopathy group (IIM): dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM). These are primary inflammatory muscle diseases with substantial muscle weakening in their course. Everyone of the entities belonging to IIM is possessed of a particular clinical picture, as well as of histological and immunological features. In this paper, there have been briefly described classification, clinical pictures, supplementary diagnostic tests, treatment and up-to date views on IIM etiopathogenesis.

Document emailed within 1 workday
Secure & encrypted payments

Figarella-Branger, D.; Lacroix, C.; Coquet, M.; Gherardi, R.; Pellissier, J.F. 2001: Idiopathic inflammatory myopathies Annales de Pathologie 21(3): 279-284
Lundberg, I.E.; Forbess, C.J. 2008: Mortality in idiopathic inflammatory myopathies Clinical and Experimental Rheumatology 26(5 Suppl 51: S109-S114
Dugan, E.M.; Huber, A.M.; Miller, F.W.; Rider, L.G.; Bowyer, S.; Feldman, B.M.; Danko, K.; Garcia de la Torre, I.; Lang, B.; Lindsley, C.; Malleson, P.; Pachman, L.M.; Plotz, P.H.; Rennebohm, R.; Serratrice, J.; Sherry, D.; Sontheimer, R.; Song, Y.W.; Targoff, I.; Turner, M.; Vencovsky, J.; von Muhlen, C.A.; Werth, V.P.; Wortmann, R. 2009: Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies Dermatology Online Journal 15(2): 1
Fraser, D.D.; Frank, J.A.; Dalakas, M.; Miller, F.W.; Hicks, J.E.; Plotz, P. 1991: Magnetic resonance imaging in the idiopathic inflammatory myopathies Journal of Rheumatology 18(11): 1693-1700
Pipitone, N.; Salvarani, C. 2007: Established and new treatments of the idiopathic inflammatory myopathies: dermatomyositis and polymyositis Clinical and Experimental Rheumatology 25(6): 896-906
Megens-de Letter, M.A.; Visser, L.H.; van Doorn, P.A.; Savelkoul, H.F. 1999: Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy European Cytokine Network 10(4): 471-478
De Vita, S.; Fossaluzza, V. 1992: Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of the literature Acta Neurologica Belgica 92(4): 215-227
Scoppetta, C.; Casali, C.; D'Agostini, S.; Pauri, F.; Amabile, G. 1988: Inflammatory myopathies Rivista di Neurologia 58(1): 11-14
Larrauri, B.J.; Fernández Romero, D.S.; Juri, M.C.; Malbrán, A. 2016: Relapses in inflammatory myopathies Medicina 76(6): 379-382
Radhakrishnan, V.V.; Nair, M.D.; Kuruvilla, A.; Radhakrishnan, K. 1997: Inflammatory myopathies--a clinicopathologic study Indian Journal of Pathology and Microbiology 40(3): 315-320
Armbrustmacher, V.W.; Griffin, J.L. 1981: Pathology of inflammatory and metabolic myopathies Pathology Annual 16 Pt 1: 15-60
Chakour, R.; Leimgruber, A.; Bart, P.-A.; Spertini, F.ço. 2009: Therapeutic strategies in idiopatic inflammatory myopathies Revue Medicale Suisse 5(199): 812-818
Zámecník, J.; Vytásek, R.; Vencovský, J.; Vilím, V. 2011: Immunolocalization of protein-bound 3-nitrotyrosine in inflammatory myopathies Ceskoslovenska Patologie 47(2): 62-65
Bertorini, T.E. 1998: Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis Comprehensive Therapy 24(10): 494-502
Rowińska-Marcińska, K.; Szmidt-Sałkowska, E.; Kowalska, E.; Błaszczyk, M.; Drac, H.; Zakrzewska-Pniewska, B.; Karwańska, A.; Jabłońska, S.; Hausmanowa-Petrusewicz, I. 1994: Diagnostic yield of electrophysiological and immunological studies in inflammatory myopathies Neurologia i Neurochirurgia Polska 28(1 Suppl 1: 103-113
Kojima, S.; Takagi, A. 1993: Aberrant expression of major histocompatibility complex class Ii antigen in inflammatory myopathies Rinsho Shinkeigaku 33(6): 612-619
Gamstorp, I. 1971: Characteristic clinical findings in some neurogenic myopathies and in some myogenic myopathies causing muscular weakness, hypotonia and atrophy in infancy and early childhood Birth Defects Original Article Series 7(2): 72-81
Peiffer, J.; Bähr, M. 1987: Anomalies in perifascicular muscle fibers as an differential-diagnostic criterion. I. Perifascicular atrophy in inflammatory myopathies Clinical Neuropathology 6(3): 123-132
Reimund, J.M.; Duclos, B.; Baumann, R. 1996: Genetics and chronic idiopathic inflammatory diseases of the intestines Annales de Medecine Interne 147(3): 178-184
Garcia-Hernandez, F.J.; Gonzalez-Leon, R.; Castillo-Palma, M.J.; Sanchez-Roman, J. 2011: Rituximab is effective in the treatment of patients with idiopathic inflammatory myopathy Clinical and Experimental Rheumatology 29(2): 363-364